Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 SEK | +0.10% | +0.39% | +61.76% |
06-18 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
06-18 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.76% | 1.04B | |
+7.95% | 72.21B | |
+14.98% | 9.14B | |
-24.60% | 4.33B | |
+15.26% | 4.28B | |
+28.46% | 4.15B | |
+8.86% | 2.19B | |
-35.98% | 1.98B | |
+7.76% | 1.98B | |
-47.71% | 1.68B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Transcript : Calliditas Therapeutics AB, Q1 2024 Earnings Call, May 23, 2024